MYRIAD GENETICS INC. - COMMON STOCK
19.80
29-April-24 15:59:58
15 minutes delayed
Stocks
+1.62
+8.91%
Today's range
18.34 - 19.88
ISIN
N/A
Source
NASDAQ
-
Myriad Genetics Announces New $90 Million Asset-Based Credit Facility
06 Jul 2023 08:30:00 By Nasdaq GlobeNewswire
-
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform
12 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Myriad Genetics to Participate in Goldman Sachs Healthcare Conference
07 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023
01 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics
31 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
24 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics Earns 2023 Great Place to Work Certification™
08 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics to Participate in BofA Securities Healthcare Conference
02 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics to Release First Quarter Financial Results on May 3, 2023
26 Apr 2023 16:05:00 By Nasdaq GlobeNewswire
-
19 Apr 2023 07:05:00 By Nasdaq GlobeNewswire
-
18 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
02 Mar 2023 09:15:00 By Nasdaq GlobeNewswire
-
Myriad Genetics Applauds New Expanded Carrier Screening Practice Guidelines from NSGC
01 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023
22 Feb 2023 07:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics to Participate in Upcoming Healthcare Conferences
09 Feb 2023 07:15:00 By Nasdaq GlobeNewswire
-
07 Feb 2023 07:15:00 By Nasdaq GlobeNewswire
-
Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities
05 Jan 2023 07:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 08:00:01 By Nasdaq GlobeNewswire